We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.7B
AUM Growth
+$129M
Cap. Flow
-$29.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
38.9%
Holding
1,194
New
46
Increased
298
Reduced
730
Closed
120

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$37.6M
2
AVGO icon
Broadcom
AVGO
+$3.78M
3
EXAS
Exact Sciences
EXAS
+$3.05M
4
BKNG icon
Booking.com
BKNG
+$2.84M
5
NEE icon
NextEra Energy
NEE
+$2.62M

Sector Composition

Rank Sector Weight
1 Technology 47.26%
2 Healthcare 11.3%
3 Consumer Discretionary 9.84%
4 Communication Services 9.16%
5 Financials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERV
1026
DELISTED
Verve Therapeutics
VERV
$136K 0.01%
27,914
-38,883
-58% -$244K
VYGR icon
1027
Voyager Therapeutics
VYGR
$187M
$133K ﹤0.01%
16,762
-2,154
-11% -$18.1K
EOLS icon
1028
Evolus
EOLS
$394M
$130K ﹤0.01%
+11,995
New +$148K
AG icon
1029
First Majestic Silver
AG
$8.05B
$129K ﹤0.01%
21,711
-3,176
-13% -$22K
LXP icon
1030
LXP Industrial Trust
LXP
$3.53B
$128K ﹤0.01%
2,812
-335
-11% -$14.7K
TDOC icon
1031
Teladoc Health
TDOC
$1.58B
$128K ﹤0.01%
13,045
-29,309
-69% -$357K
GNW icon
1032
Genworth Financial
GNW
$3.8B
$127K ﹤0.01%
20,985
-3,346
-14% -$20.8K
ZNTL icon
1033
Zentalis Pharmaceuticals
ZNTL
$308M
$126K ﹤0.01%
30,892
-15,510
-33% -$173K
RUN icon
1034
Sunrun
RUN
$2.37B
$126K ﹤0.01%
+10,583
New +$130K
TTI icon
1035
TETRA Technologies
TTI
$1.23B
$124K ﹤0.01%
35,900
-513
-1% -$2.05K
TNGX icon
1036
Tango Therapeutics
TNGX
$4.34B
$119K ﹤0.01%
13,893
-20,404
-59% -$158K
AAL icon
1037
American Airlines Group
AAL
$9.58B
$117K ﹤0.01%
10,296
-128
-1% -$1.68K
NGD
1038
DELISTED
New Gold Inc
NGD
$117K ﹤0.01%
59,747
+207
+0.3% +$394
FSM icon
1039
Fortuna Silver Mines
FSM
$2.59B
$113K ﹤0.01%
23,109
-3,462
-13% -$17.5K
SHO icon
1040
Sunstone Hotel Investors
SHO
$2.19B
$113K ﹤0.01%
10,779
-1,047
-9% -$10.8K
EYPT icon
1041
EyePoint Inc
EYPT
$1.02B
$111K ﹤0.01%
12,793
-2,549
-17% -$35.6K
COTY icon
1042
Coty
COTY
$2.33B
$106K ﹤0.01%
10,571
-4,300
-29% -$46.1K
CWK icon
1043
Cushman & Wakefield Ltd
CWK
$2.98B
$105K ﹤0.01%
+10,096
New +$104K
SVRA icon
1044
Savara
SVRA
$1.13B
$105K ﹤0.01%
+26,017
New +$116K
NPKI
1045
NPK International
NPKI
$1.21B
$103K ﹤0.01%
12,339
-7,059
-36% -$54.4K
SAND
1046
DELISTED
Sandstorm Gold
SAND
$102K ﹤0.01%
18,684
-2,729
-13% -$15.1K
HUMA icon
1047
Humacyte
HUMA
$168M
$97.3K ﹤0.01%
+20,271
New +$106K
JBLU icon
1048
JetBlue
JBLU
$1.96B
$95.4K ﹤0.01%
15,659
-2,397
-13% -$14.4K
DRH icon
1049
Diamondrock Hospitality Co
DRH
$2.63B
$94K ﹤0.01%
11,129
-950
-8% -$8.27K
SILV
1050
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$90.7K ﹤0.01%
11,131
-1,604
-13% -$13.1K

Similar funds

Profund Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Profund Advisors held 1,194 positions worth $2.7B, up 5% from $2.57B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Profund Advisors's Q2 2024 filing shows 46 new, 298 increased, 730 reduced and 120 closed positions. Its largest new stake was HubSpot: 3,324 shares worth $1.96M. The largest sale was Apple, an estimated $22.4M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q2 2024 buy was HubSpot: 3,324 shares worth $1.96M.
  • Profund Advisors added most to NVIDIA in Q2 2024, an estimated $37.6M increase.
  • Profund Advisors's biggest Q2 2024 reduction was Apple, cutting an estimated $22.4M.
  • Profund Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $3.01M.
  • Profund Advisors's ten largest holdings make up 39% of its $2.7B portfolio in Q2 2024.
  • Profund Advisors opened 46 new positions and closed 120 in Q2 2024.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $2.7B.

Based on Profund Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.